Valink Therapeutics
Latest round
- Series A
Last raised
- Oct 2025
Total raised
- $12M
Investors
- 6
About Valink Therapeutics
Valink Therapeutics Ltd.Founded in 2020 and headquartered in Cambridge, Massachusetts, Valink Therapeutics Ltd. specializes in the research and development of bispecific ADCs aimed at addressing various cancers.Valink Therapeutics focuses on innovative antibody-drug conjugates (ADCs), specifically next-generation bispecific ADCs. Utilizing their proprietary "V-Gate" approach, these products selectively target cancer cells based on molecular markers, addressing challenges in drug resistance and treatment variability.Valink Therapeutics generates revenue through strategic partnerships and collaborations within the biopharmaceutical sector, particularly in oncology.80 mn to enhance its oncology pipeline and expand its market presence. Focused on launching new bispecific ADC products, the company aims to penetrate additional markets, including Europe and Asia, by 2024. Their strategy emphasizes building partnerships with healthcare organizations to facilitate the adoption of their innovative therapies.
Who invested in Valink Therapeutics
6 investors across 1 round
See all investors in Valink Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 20, 2025
Amount
$12M
Investors
Questions about Valink Therapeutics
Who invested in Valink Therapeutics?
Valink Therapeutics has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Valink Therapeutics raised?
Valink Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Valink Therapeutics last raise money?
Valink Therapeutics's most recent round on record is a Series A, in Oct 2025.
What does Valink Therapeutics do?
Valink Therapeutics is a biotechnology company.
Where is Valink Therapeutics headquartered?
Valink Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Valink Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Valink Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Valink Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.